Contents Glucose (11%), amino acids & electrolyte (Vamin 18 Novum), fat e mulsion (Intralipid 20%) Indications Parenteral

nutrition for adult & childn >2 yr when oral or enter al nutrition is impossible, insufficient or contraindicated. Click to view Kabiven Peripheral detailed prescribing infomation Dosage Adult & childn >10 yr 27-40 mL/kg/day. Childn 2-10 yr 14-28 mL/kg. Max: 40 mL/kg/day. Click to view Kabiven Peripheral detailed prescribing infomation Overdosage View Kabiven Peripheral overdosage for action to be taken in the event of an overdose. Contraindications Hypersensitivity to egg or soy protein. Severe hyperlipa emia; severe liver & renal disorders, blood coagulation disorders. Inborn errors of amino acid metabolism, acute shock, hyperglycemia, elevated serum levels. Ac ute pulmonary oedema, hyperhydration, cardiac insufficiency & hypotonic dehydrat ion. Haemophagocytotic syndrome. Unstable conditions. Childn <2 yr. Click to view Kabiven Peripheral detailed prescribing infomation Special Precautions Impaired lipid metabolism, uncompensated diabetes mellit us, pancreatitis, impaired liver function, hypothyroidism or sepsis. Metabolic a cidosis. Monitor serum triglyceride conc, serum glucose, electrolytes & osmolari ty, fluid balance, acid-base status & liver enzyme function test, blood cell cou nt & coagulation. Pregnancy & lactation. Click to view Kabiven Peripheral detailed prescribing infomation Adverse Drug Reactions Rise in body temp, shivering, chills & nausea/vomiting. Transient increase in liver enzymes. Rarely hypersensitivity reactions, resp sym ptoms, hyper/hypotension. Haemolysis, reticulocytosis, abdominal pain, headache, tiredness & priapism. Fat overload syndrome. View ADR Monitoring Form Drug Interactions Heparin increased plasma lipolysis followed by transient increase in triglyceride clearance. Vit K1 could affect coagulation in patients receiving coumarin derivatives. View more drug interactions with Kabiven Peripheral Caution For Usage For caution against possible variation of physical aspec t of medicine... click to view Kabiven Peripheral detailed prescribing infomatio n Storage View Kabiven Peripheral storage conditions for details to ensure optimal shelf-life. Description View Kabiven Peripheral description for details of the chemical structure and excipients (inactive components). Mechanism of Action View Kabiven Peripheral mechanism of action for pharmaco dynamics and pharmacokinetics details. MIMS Class Parenteral Nutritional Products ATC Classification C05BB56 - glucose, combinations ; Belongs to the class of sclerosing agent used as local injection in antivaricose therapy.